Literature DB >> 9870011

Electrophysiologic characteristics of a dilated atrium in patients with paroxysmal atrial fibrillation and atrial flutter.

Y J Chen1, S A Chen, C T Tai, W C Yu, A N Feng, Y A Ding, M S Chang.   

Abstract

This study investigated the difference of atrial electrophysiologic characteristics between a normal and dilated atrium and compared them among patients with paroxysmal atrial fibrillation and flutter. Twenty-seven patients with paroxysmal atrial fibrillation and 28 patients with paroxysmal atrial flutter were divided into four subgroups, according to the presence of a normal atrium or bilateral atrial enlargement. Thirty patients without atrial arrhythmia (20 patients with normal atrium and 10 patients with bilateral atrial enlargement) were included in control group. The atrial refractoriness in patients with a dilated atrium was longer than those with normal atrial size. In patients with paroxysmal atrial fibrillation and patients of control group, the P-wave duration and interatrial conduction velocity with or without atrial enlargement were similar. However, in patients with paroxysmal atrial flutter, P-APCS (86 +/- 10 ms vs. 73 +/- 9 ms, p < 0.05) and P-ADCS (109 +/- 9 ms vs. 95 +/- 9 ms, p < 0.05) in patients with a dilated atrium were longer than in patients with a normal atrium. The patients with paroxysmal atrial fibrillation or atrial flutter all demonstrated longer P-wave duration and interatrial conduction time than control group. Among the groups with a normal atrium or a dilated atrium, atrial refractoriness in patients with paroxysmal atrial flutter was shorter than that in control group. Moreover, in the patients with a normal atrium, the potential minimal wavelength in control group (6.6 +/- 1.7) was longer than that of paroxysmal atrial fibrillation (5.3 +/- 1.1), or atrial flutter (5.0 +/- 1.2). These findings suggest that atrial electrophysiologic characteristics of a dilated atrium were different from those of normal atrium, and these changes were different between paroxysmal atrial fibrillation and flutter. Multiple factors are considered to be related to the genesis of atrial tachyarrhythmias.

Entities:  

Mesh:

Year:  1998        PMID: 9870011     DOI: 10.1023/a:1009759717250

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  26 in total

1.  Mode of onset of atrial fibrillation in the Wolff-Parkinson-White syndrome: how important is the accessory pathway?

Authors:  O Fujimura; G J Klein; R Yee; A D Sharma
Journal:  J Am Coll Cardiol       Date:  1990-04       Impact factor: 24.094

2.  Electrocardiographic patterns and results of radiofrequency catheter ablation of clockwise type I atrial flutter.

Authors:  N Saoudi; M Nair; A Abdelazziz; H Poty; A Daou; F Anselme; B Letac
Journal:  J Cardiovasc Electrophysiol       Date:  1996-10

3.  Some observations on the mechanism of pressure related atrial fibrillation.

Authors:  D A Sideris; S T Toumanidis; M Thodorakis; K Kostopoulos; E Tselepatiotis; C Langoura; T Stringli; S D Moulopoulos
Journal:  Eur Heart J       Date:  1994-11       Impact factor: 29.983

4.  Electrophysiological effect of volume load in isolated canine hearts.

Authors:  H Calkins; W L Maughan; D A Kass; K Sagawa; J H Levine
Journal:  Am J Physiol       Date:  1989-06

5.  Validation of double-spike electrograms as markers of conduction delay or block in atrial flutter.

Authors:  F G Cosio; F Arribas; J M Barbero; C Kallmeyer; A Goicolea
Journal:  Am J Cardiol       Date:  1988-04-01       Impact factor: 2.778

6.  Demonstration of an area of slow conduction in human atrial flutter.

Authors:  B Olshansky; K Okumura; P G Hess; A L Waldo
Journal:  J Am Coll Cardiol       Date:  1990-12       Impact factor: 24.094

7.  Electrophysiological effects of transient aortic occlusion in intact canine heart.

Authors:  D G Benditt; J M Kriett; H G Tobler; C C Gornick; B L Detloff; R W Anderson
Journal:  Am J Physiol       Date:  1985-11

8.  Mechanisms for atrial arrhythmias associated with cardiomyopathy: a study of feline hearts with primary myocardial disease.

Authors:  P A Boyden; L P Tilley; A Albala; S K Liu; J J Fenoglio; A L Wit
Journal:  Circulation       Date:  1984-05       Impact factor: 29.690

9.  Electrophysiological properties in chronic lone atrial fibrillation.

Authors:  K Kumagai; S Akimitsu; K Kawahira; F Kawanami; Y Yamanouchi; T Hiroki; K Arakawa
Journal:  Circulation       Date:  1991-10       Impact factor: 29.690

10.  Accessory pathway and atrioventricular node reentrant tachycardia in elderly patients: clinical features, electrophysiologic characteristics and results of radiofrequency ablation.

Authors:  S A Chen; C E Chiang; C J Yang; C C Cheng; T J Wu; S P Wang; B N Chiang; M S Chang
Journal:  J Am Coll Cardiol       Date:  1994-03-01       Impact factor: 24.094

View more
  10 in total

Review 1.  Mechanisms underlying the development of atrial arrhythmias in heart failure.

Authors:  Vias Markides; Nicholas S Peters
Journal:  Heart Fail Rev       Date:  2002-07       Impact factor: 4.214

Review 2.  Catheter mapping of spontaneous and induced atrial fibrillation in man.

Authors:  S Saksena; A Shankar; A Prakash; R B Krol
Journal:  J Interv Card Electrophysiol       Date:  2000-01       Impact factor: 1.900

Review 3.  Electrophysiologic assessment in selecting patients for multisite atrial pacing.

Authors:  P Delfaut; S Saksena
Journal:  J Interv Card Electrophysiol       Date:  2000-01       Impact factor: 1.900

4.  Analysis of P wave and P dispersion in children with secundum atrial septal defect.

Authors:  T F Ho; E L Chia; W C Yip; K Y Chan
Journal:  Ann Noninvasive Electrocardiol       Date:  2001-10       Impact factor: 1.468

Review 5.  Atrial Septal Defect and Atrial Fibrillation: The Known and Unknown.

Authors:  George E Blake; Dhanunjaya Lakkireddy
Journal:  J Atr Fibrillation       Date:  2008-09-16

6.  Pirfenidone prevents the development of a vulnerable substrate for atrial fibrillation in a canine model of heart failure.

Authors:  Ken W Lee; Thomas H Everett; Dulkon Rahmutula; Jose M Guerra; Emily Wilson; Chunhua Ding; Jeffrey E Olgin
Journal:  Circulation       Date:  2006-10-09       Impact factor: 29.690

Review 7.  Mechanisms of termination and prevention of atrial fibrillation by drug therapy.

Authors:  A J Workman; G L Smith; A C Rankin
Journal:  Pharmacol Ther       Date:  2011-02-18       Impact factor: 12.310

8.  Alterations in atrial electrophysiology and tissue structure in a canine model of chronic atrial dilatation due to mitral regurgitation.

Authors:  Sander Verheule; Emily Wilson; Thomas Everett; Sujata Shanbhag; Catherine Golden; Jeffrey Olgin
Journal:  Circulation       Date:  2003-05-05       Impact factor: 29.690

9.  P-wave dispersion and its relationship with the severity of the disease in patients with stable coronary artery disease.

Authors:  Fatih Akin; Inci Firatli; Fahrettin Katkat; Tevfik Gurmen; Burak Ayca; Muhsin Kalyoncuoglu; Okay Abaci; Mustafa Sari; Murat Ersanli; Serdar Kucukoglu; Zerrin Yigit
Journal:  North Clin Istanb       Date:  2014-12-08

10.  Exploring Refractoriness as an Adjunctive Electrical Biomarker for Staging of Atrial Fibrillation.

Authors:  Lianne N van Staveren; Natasja M S de Groot
Journal:  J Am Heart Assoc       Date:  2020-11-26       Impact factor: 5.501

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.